Legal cannabis linked to higher disorder rates in seniors

The Impact of Recreational Cannabis Laws on Cannabis-Related Disorders in the US Medicare Population.

American journal of public health β€’ β€’ Moderately Relevant
πŸ€–

AI Summary

This study analyzed Medicare claims data from 2010-2022 to examine how recreational cannabis legalization affects cannabis-related disorders (CRDs) in older adults across the United States. Researchers compared health outcomes in states that passed recreational cannabis laws and opened dispensaries against states without legalization, using statistical models to isolate the effects of legalization. The findings reveal concerning trends: following legalization, CRD diagnoses increased by 19.73 cases per 10,000 Medicare enrollees, and healthcare claims involving CRDs jumped 20.56 per 10,000 enrollees. Similarly, when recreational dispensaries actually opened, cases rose 14.14 per 10,000 enrollees with 13.98 additional claims per 10,000.

The research suggests that increased access to cannabis through legal dispensaries correlates with higher rates of cannabis-related disorders among seniors, which may include conditions like cannabis use disorder, dependence, and acute health complications. While the study doesn't prove legalization directly caused these increases, the timing and statistical significance suggest a strong association. The implications are particularly important for older adults, who may face unique risks from cannabis use including interactions with medications, cognitive effects, and falls. The authors emphasize that policymakers considering cannabis legalization should weigh these potential harms against other benefits, particularly regarding vulnerable populations like the elderly who already face complex health management challenges.

πŸ“„ Original Abstract

Objectives. To investigate the effects of recreational cannabis laws (RCLs) on the rate of Medicare fee-for-service enrollees with cannabis-related disorders (CRDs) and claims involving CRDs. Methods. We used Medicare fee-for-service inpatient and outpatient claims from 2010 to 2022 to compare CRD outcomes in US states with and without effective RCLs and open recreational cannabis dispensaries (RCDs) using difference-in-difference models. We estimated the impact of RCLs and RCDs on the overall rate of Medicare enrollees with CRD per 10 000 enrollees and the rate of claims with CRD per 10 000 enrollees at the stateβ€’year level (n = 663). Results. We found statistically significant increases in CRD outcomes following RCLs (19.73 patients per 10 000 enrollees [P < .001]; 20.56 claims per 10 000 enrollees [P = .005]) and RCDs (14.14 patients per 10 000 enrollees [P < .001]; 13.98 claims per 10 000 enrollees [P = .004]). Conclusions. Given that RCLs were associated with increased rates of CRD diagnoses and claims including CRD among Medicare fee-for-service enrollees, states considering implementation of RCLs should consider the negative harms of legalization, particularly for older adults. (Am J Public Health. Published online ahead of print April 23, 2026:e1-e4. https://doi.org/10.2105/AJPH.2026.308522).

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.